Suvoda wraps up first half of 2021 with strong business growth, geographical expansion, and new product enhancements
PR90783
CONSHOHOCKEN, Pa., July 26, 2021 /PRNewswire=KYODO JBN/ --
- Clinical trial software innovator reports record quarter for business
bookings in Q2
Suvoda LLC, an innovator in clinical trial software, today announced that it
saw significant business growth in the first half of 2021 with some of the
major pharma and biotech firms as well as CROs selecting and implementing its
IRT solution. In addition, Suvoda released multiple IRT product enhancements
and expanded its presence in North America, Europe, and Japan.
Logo - https://mma.prnewswire.com/media/1039295/Suvoda_Logo.jpg
The company reported 50% growth in bookings compared to the same period of last
year while surpassing a total of 800 trials going live on its IRT system since
the company's founding. Well-known in the industry for its excellence in
professional services and customer support, Suvoda has maintained a customer
satisfaction score of above 9 (out of 10) since it started conducting the
survey in 2018 with more than 90% of customers returning to Suvoda for their
clinical trial needs.
Suvoda also released the latest version of its IRT software which includes
enhancements to its capabilities to support virtual and decentralized clinical
trials, further augmenting the flexibility and adaptability of its
industry-leading supply chain management offering.
At the same time, Suvoda has been scaling its organization to support growth
and added experienced technology executives in product and marketing, as well
as a senior executive in Japan to its leadership team.
"It is an exciting time for Suvoda and the industry at a macro level," said
Jagath Wanninayake, President & CEO, Suvoda. "I am immensely grateful to our
customers for continuing to entrust us with their lifeblood - their clinical
programs, and to the Suvoda team members for their relentless commitment to
excellence and their uncompromising focus on customer service."
In July, Suvoda was recognized as a winner of the Top Technology Company
category at the annual Philadelphia Alliance for Capital and Technologies
(PACT) Enterprise Awards, acknowledging its continuous innovation, leadership,
and role in transforming healthcare and technology fields worldwide.
About Suvoda LLC
Suvoda is an innovative SaaS company, focused on transforming clinical trials
using the power of technology. Suvoda's Interactive Response Technology (IRT)
system solves complex patient randomization and clinical trial supply chain
challenges, so that customers have peace of mind to focus on their patients.
Suvoda IRT sets clinical trials up for success by offering a variety of
configurable and customizable features, powerful reporting, and advanced
functionality, built to support complex and innovative study designs.
Headquartered in Conshohocken, PA, Suvoda has offices and staff around the
world, offering exceptional customer and advisory services to biopharmaceutical
companies and clinical research organizations of all sizes. Learn more at
www.suvoda.com.
SOURCE Suvoda LLC
CONTACT: Danielle Chmelewski, 14849474758, dchmelewski@suvoda.com
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。